Improvement in solubility and bioavailability of puerarin by mechanochemical preparation

References

• Quan DQ, Xu GX, Wu XG. (2007). Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin. Chem Pharm Bull, 55:800–803.
   PubMed Web of Science ®Google Scholar
• Fang CC, Lin M, Sun CM, Liu HM, Lang HY. (1974). [Studies on flavones of Radix puerariae]. Zhonghua Yi Xue Za Zhi, 5:271–274.
   PubMedGoogle Scholar
• Gao FY.(2003). Advances of pharmacological effects of puerarin. Chin Tradit Herb Drug, 34:7–8.
   Google Scholar
• Shi RL, Zhang JJ. (2003). Protective effect of puerarin on vascular endothelial cell apoptosis induced by chemical hypoxia in vitro. Acta Pharm Sin, 38:103–107.
   Google Scholar
• Ren F, Jing Q, Shen Y, Ma H, Cui J. (2006). Quantitative determination of puerarin in dog plasma by HPLC and study on the relative bioavailability of sustained release tablets. J Pharm Biomed Anal, 41:549–553.
   PubMed Web of Science ®Google Scholar
• Choo MK, Park EK, Yoon HK, Kim DH. (2002). Antithrombotic and antiallergic activities of daidzein, a metabolite of puerarin and daidzin produced by human intestinal microflora. Biol Pharm Bull, 25:1328–1332.
   PubMed Web of Science ®Google Scholar
• Xuan B, Zhou YH, Yang RL, Li N, Min ZD, Chiou GC. (1999). Improvement of ocular blood flow and retinal functions with puerarin analogs. J Ocul Pharmacol Ther, 15:207–216.
   PubMed Web of Science ®Google Scholar
• Xu JG . (2009). Study on adverse reactions and correlation factor induced by puerarin injection during appling. Chin J Mod Drug Appl, 3:21–22.
   Google Scholar
• Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC, Cheng JT. (2003). Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod, 66:788–792.
   PubMed Web of Science ®Google Scholar
• Cirri M, Rangoni C, Maestrelli F, Corti G, Mura P. (2005). Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes. Drug Dev Ind Pharm, 31:697–707.
   PubMed Web of Science ®Google Scholar
• Nie S, Zhang S, Pan W, Liu Y. (2011). In vitro and in vivo studies on the complexes of glipizide with water-soluble ß-cyclodextrin-epichlorohydrin polymers. Drug Dev Ind Pharm, 37:606–612.
   PubMed Web of Science ®Google Scholar
• Castillo JA, Palomo-Canales J, Garcia JJ, Lastres JL, Bolas F, Torrado JJ. (1999). Preparation and characterization of albendazole beta-cyclodextrin complexes. Drug Dev Ind Pharm, 25:1241–1248.
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen M, Diao GW.(2011). Preparation and electrochemical behavior of water-soluble inclusion complex of ferrocene with β-cyclodextrin polymer. Electrochimi Acta, 56:5129–5136.
   Web of Science ®Google Scholar
• Barzegar-Jalali M, Valizadeh H, Shadbad MR, Adibkia K, Mohammadi G, Farahani A, Arash Z, Nokhodchi A.(2010). Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide). Powder Technol, 197:150–158.
   Web of Science ®Google Scholar
• Colombo I, Grassi G, Grassi M. (2009). Drug mechanochemical activation. J Pharm Sci, 98:3961–3986.
   PubMed Web of Science ®Google Scholar
• Kim J, Jung DH, Rhee H, Choi SH, Sung MJ, Choi WS. (2008). Improvement of bioavailability of water insoluble drugs: estimation of intrinsic bioavailability. Korean J Chem Eng, 25:171–175.
   Web of Science ®Google Scholar
• Crowley KJ, Zografi G. (2002). Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability. J Pharm Sci, 91:492–507.
   PubMed Web of Science ®Google Scholar
• Boldyrev VV, Shakhtshneider TP, Chizhik SA. (2005). On the mechanism of solubilization of drugs in the presence of poorly soluble additives. Int J Pharm, 295:177–182.
   PubMedGoogle Scholar
• Dushkin AV, Rykova ZU, Shakhtshneider TP, Boldyrev VV. (1994). Aggregation processes in the reactivity of mechanically activated organic solids. Int J Mechanochem Mech Alloying, 1:48–55.
   Google Scholar
• Bragagni M, Maestrelli F, Mura P. (2010). Physical chemical characterization of binary systems of prilocaine hydrochloride with triacetyl-β-cyclodextrin. J Incl Phenom Macro, 68:437–445.
   Web of Science ®Google Scholar
• Delogu F, Deidda C, Mulas G, Schiffini L, Cocco G. (2004). A quantitative approach to mechanochemical processes. J Mater Sci, 39:5121–5124.
   Web of Science ®Google Scholar
• Lin SY, Hsu CH, Sheu MT. (2010). Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process. Int J Pharm, 53:799–803.
   Google Scholar
• Fukami T, Furuishi T, Suzuki T, Hidaka S, Ueda H, Tomono K . (2006). Improvement in solubility of poorly water soluble drug by cogrinding with highly branched cyclic dextrin. J Incl Phenom Macro, 56:61–64.
   Google Scholar
• Voinovich D, Perissutti B, Grassi M, Passerini N, Bigotto A. (2009). Solid state mechanochemical activation of Silybum marianum dry extract with betacyclodextrins: Characterization and bioavailability of the coground systems. J Pharm Sci, 98:4119–4129.
   PubMed Web of Science ®Google Scholar
• Liu X, Yu B, Wang N, Zhang B, Du F, He C et al. (2010). A validated stability-indicating HPLC method for the determination of PEGylated puerarin in aqueous solutions. J Chromatogr B Analyt Technol Biomed Life Sci, 878:2061–2066.
   PubMed Web of Science ®Google Scholar
• Yan B, Wang W, Zhang L, Xing D, Wang D, Du L. (2006). Determination of puerarin in rat cortex by high-performance liquid chromatography after intravenous administration of Puerariae flavonoids. Biomed Chromatogr, 20:180–184.
   PubMed Web of Science ®Google Scholar
• Tatiana VN, Sara CC, Eugenia N, Oliveira MBPP.(2009). Optimization of matrix solid-phase dispersion extraction method for the analysis of isoflavones in Trifolium pratense. J Chromatogr A, 1216:3720–3724.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Connors KA. (1965). . Advances in Analytical Chemistry and Instrumentation, Chapter 4Phase Solubility Studies; Interscience: New York, pp. 117–212.
   Google Scholar
• ICH Q1C and Q1A: “Stability Testing of New Dosage Forms”.
   Google Scholar
• Echezarreta–Lopez M, Torres–Labandeira JJ, Castineiras–Seijo L, Santana–Penin L, Vila–Jato JL. (2000). Complexation of the interferon inducer, bropirimine, with hydroxypropyl-β-cyclodextrin. Eur J Pharm Sci, 9:381–386.
   PubMed Web of Science ®Google Scholar
• Esclusa–Diaz MT, Torres–Labandeira JJ, Kata M, Vila–Jato JL.(1994). Inclusion complexation of gilbenclamide with 2-hydroxypropyl-β-cyclodextrin in solution and in solid state. Eur J Pharm Sci, 1:291–296.
   Web of Science ®Google Scholar
• Mura P, Adragna E, Rabasco AM, Moyano JR, Pérez-Martìnez JI, Arias MJ et al. (1999). Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems. Drug Dev Ind Pharm, 25:279–287.
   PubMed Web of Science ®Google Scholar
• Yue PF, Yuan HL, Li XY, Yang M, Zhu WF.(2010). Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Int J Pharm, 387:139–146.
   PubMed Web of Science ®Google Scholar
• Al-Marzouqi AH, Elwy HM, Shehadi I, Adem A. (2009). Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques. J Pharm Biomed Anal, 49:227–233.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang DJ, Chen SL, Chen SB, Chan AS. (2008). Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. Pharm Res, 25:563–577.
   PubMed Web of Science ®Google Scholar
• Bandarkar FS, Vavia PR. (2011). An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in ß-cyclodextrin. Drug Dev Ind Pharm, 37:1318–1328.
   PubMed Web of Science ®Google Scholar
• Gupta MK, Vanwert A, Bogner RH. (2003). Formation of physically stable amorphous drugs by milling with Neusilin. J Pharm Sci, 92:536–551.
   PubMed Web of Science ®Google Scholar
• Sharma P, Denny WA, Garg S. (2009). Effect of wet milling process on the solid state of indomethacin and simvastatin. Int J Pharm, 380:40–48.
   PubMed Web of Science ®Google Scholar